NEW YORK (GenomeWeb News) – PBL Assay Science announced today a licensing agreement to provide human cell-expressed cytokines and growth factors from HumanZyme to researchers.
The deal, which takes effect this month, covers about 50 HCE cytokines and growth factors, including members of the human TGF beta, fibroblast growth factor, hematopoietin and interleukin, and tyrosine kinase receptor signaling families, as well as TNF-alpha.
Financial and other terms of the deal were not disclosed.
"HumanZyme's leadership and innovations in authentic human proteins provide a perfect complement to our unique cytokine and interferon reagents, ELISA, and assay service offerings," PBL CEO Robert Pestka said in a statement. "Introducing these proteins to our product line enhances our ability to help scientists approach their experiments using more biologically relevant research tools."
Chicago-based HumanZyme provides recombinant proteins from human cells and is a preferred outsourcing supplier of human protein production. PBL provides products, assay services, and information about interferons, cytokines, antibodies, ELISAs, and assay science.